Is schizophrenia a neurodegenerative disease? evidence from age-related decline of brain-derived neurotrophic factor in the brains of schizophrenia patients and matched nonpsychiatric controls

Neurodegenerative Diseases

Volumn 15, Issue 1, 2015, Pages 38-44

  Rao, Jagadeesh ^a   Chiappelli, Joshua ^b   Kochunov, Peter ^b   Regenold, William T ^c   Rapoport, Stanley I ^a   Hong, L Elliot L ^b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Brain; Brain derived neurotrophic factor; Postmortem; Prefrontal cortex; Schizophrenia; White matter

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADULT; AGED; ARTICLE; BRAIN; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS CALLOSUM; FEMALE; GRAY MATTER; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; PH; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHIZOPHRENIA; VERY ELDERLY; WHITE MATTER; AGING; AUTOPSY; CASE CONTROL STUDY; DIFFERENTIAL DIAGNOSIS; METABOLISM; NEURODEGENERATIVE DISEASES;

ADULT; AGED; AGED, 80 AND OVER; AGING; AUTOPSY; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; CORPUS CALLOSUM; DIAGNOSIS, DIFFERENTIAL; FEMALE; GRAY MATTER; HUMANS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PREFRONTAL CORTEX; SCHIZOPHRENIA; WHITE MATTER;

EID: 84924242123     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000369214     Document Type: Article

References (39)

1. Kraepelin E: Dementia Praecox and Paraphrenia (Barclay RM, trans-ed), 1971 facsimile ed. Huntington, Krieger, 1919
2. Knoll JL, Garver DL, Ramberg JE, Kingsbury SJ, Croissant D, McDermott B: Heterogeneity of the psychoses: is there a neuroDegenerative psychosis? Schizophr Bull 1998; 24: 365-379
3. AnDerson JE, ODonnell BF, McCarley RW, Shenton ME: Progressive changes in schizophrenia: do they exist and what do they mean? Restor Neurol Neurosci 1998; 12: 175-184
4. McGlashan TH: The profiles of clinical Deterioration in schizophrenia. J Psychiatr Res 1998; 32: 133-141
5. Breier A, Schreiber JL, Dyer J, Pickar D: National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch Gen Psychiatry 1991; 48: 239-246
6. Calabrese F, Guidotti G, Racagni G, Riva MA: Reduced neuroplasticity in aged rats: a role for the neurotrophin brain-Derived neurotrophic factor. Neurobiol Aging 2013; 34: 2768-2776
7. Hariri AR, Weinberger DR: Imaging genomics. Br Med Bull 2003; 65: 259-270
8. Nagappan G, Lu B: Activity-DepenDent modulation of the BDNF receptor TrkB: mechanisms and implications. Trends Neurosci 2005; 28: 464-471
9. Chapman TR, Barrientos RM, Ahrendsen JT, Hoover JM, Maier SF, Patterson SL: Aging and infection reduce expression of specific brain-Derived neurotrophic factor mRNAs in hippocampus. Neurobiol Aging 2012; 33: 832. e1-e14
10. Silhol M, Arancibia S, Maurice T, Tapia-Arancibia L: Spatial memory training modifies the expression of brain-Derived neurotrophic factor tyrosine kinase receptors in young and aged rats. Neuroscience 2007; 146: 962-973
11. Peng S, Wuu J, Mufson EJ, Fahnestock M: Precursor form of brain-Derived neurotrophic factor and mature brain-Derived neurotrophic factor are Decreased in the pre-clinical stages of Alzheimers disease. J Neurochem 2005; 93: 1412-1421
12. Rao JS, Kim HW, Harry GJ, Rapoport SI, Reese EA: Increased neuroinflammatory and arachidonic acid cascaDe markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients. Schizophr Res 2013; 147: 24-31
13. Durany N, Michel T, Zochling R, Boissl KW, Cruz-Sanchez FF, RieDerer P, Thome J: BrainDerived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res 2001; 52: 79-86
14. Weickert CS, HyDe TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE: Reduced brain-Derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 2003; 8: 592-610
15. Buckley PF, Mahadik S, Pillai A, Terry A Jr: Neurotrophins and schizophrenia. Schizophr Res 2007; 94: 1-11
16. Chen da C, Wang J, Wang B, Yang SC, Zhang CX, Zheng YL, Li YL, Wang N, Yang KB, Xiu MH, et al: Decreased levels of serum brainDerived neurotrophic factor in drug-naive first-episoDe schizophrenia: relationship to clinical phenotypes. Psychopharmacology (Berl) 2009; 207: 375-380
17. Jindal RD, Pillai AK, Mahadik SP, Eklund K, Montrose DM, KeshaVan MS: Decreased BDNF in patients with antipsychotic naive first episoDe schizophrenia. Schizophr Res 2010; 119: 47-51
18. Zalcman S, Endicott J: Diagnostic Evaluation after Death. New York, National Institute of Mental Health, 1983
19. Roberts SB, Hill CA, Dean B, Keks NA, Opeskin K, Copolov DL: Confirmation of the diagnosis of schizophrenia after Death using DSM-IV: a Victorian experience. Aust NZJ Psychiatry 1998; 32: 73-76
20. Li JZ, Vawter MP, Walsh DM, Tomita H, EVans SJ, Choudary PV, Lopez JF, Avelar A, Shokoohi V, Chung T, et al: Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 2004; 13: 609-616
21. EVans SJ, Choudary PV, Neal CR, Li JZ, Vawter MP, Tomita H, Lopez JF, Thompson RC, Meng F, Stead JD, et al: Dysregulation of the fibroblast growth factor system in major Depression. Proc Natl Acad Sci U S A 2004; 101: 15506-15511
22. Tomita H, Vawter MP, Walsh DM, EVans SJ, Choudary PV, Li J, Overman KM, Atz ME, Myers RM, Jones EG, et al: Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry 2004; 55: 346-352
23. SchroeDer A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M, Ragg T: The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006; 7: 3
24. Cohen J, Cohen P, West SG, Aiken LS: Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, ed 3. Mahwah, Lawrence Erlbaum Associates, 2003
25. Kim HW, Cheon Y, Modi HR, Rapoport SI, Rao JS: Effects of chronic clozapine administration on markers of arachidonic acid cascaDe and synaptic integrity in rat brain. Psychopharmacology (Berl) 2012; 222: 663-674
26. Luoni A, Berry A, Calabrese F, Capoccia S, Bellisario V, Gass P, Cirulli F, Riva MA: Delayed BDNF alterations in the prefrontal cortex of rats exposed to prenatal stress: preventive effect of lurasidone treatment during adolescence. Eur Neuropsychopharmacol 2014; 24: 986-995
27. Rizos E, Papathanasiou MA, Michalopoulou PG, Laskos E, Mazioti A, Kastania A, Vasilopoulou K, Nikolaidou P, Margaritis D, Papageorgiou C, et al: A longitudinal study of alterations of hippocampal volumes and serum BDNF levels in association to atypical antipsychotics in a sample of first-episoDe patients with schizophrenia. PLoS One 2014; 9:e87997
28. Buckley PF, Pillai A, Howell KR: Brain-Derived neurotrophic factor: findings in schizophrenia. Curr Opin Psychiatry 2011; 24: 122-127
29. Chen CC, Huang TL: Effects of antipsychotics on the serum BDNF levels in schizophrenia. Psychiatry Res 2011; 189: 327-330
30. Parks J, Svendsen D, Singer P, Foti ME: Morbidity and mortality in people with serious mental illness. Alexandria, NASMHPD, 2006
31. Bushe CJ, Taylor M, Haukka J: Mortality in schizophrenia: a measurable clinical endpoint. J Psychopharmacol 2010; 24(suppl 4): 17-25
32. Brown S: Excess mortality of schizophrenia. A meta-Analysis. Br J Psychiatry 1997; 171: 502-508
33. Saha S, Chant D, McGrath J: A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64: 1123-1131
34. Douillard-Guilloux G, Guilloux JP, Lewis DA, Sibille E: Anticipated brain molecular aging in major Depression. Am J Geriatr Psychiatry 2013; 21: 450-460
35. Tsuang MT, Woolson RF: Excess mortality in schizophrenia and affective disorDers. Do suiciDes and acciDental Deaths solely account for this excess? Arch Gen Psychiatry 1978; 35: 1181-1185
36. Dalby RB, Elfving B, Poulsen PH, Foldager L, Frandsen J, ViDebech P, Rosenberg R: Plasma brain-Derived neurotrophic factor and prefrontal white matter integrity in late-onset Depression and normal aging. Acta Psychiatr Scand 2013; 128: 387-396
37. Sato Y, Chin Y, Kato T, Tanaka Y, Tozuka Y, Mase M, Ageyama N, Ono F, Terao K, Yoshikawa Y, et al: White matter activated glial cells produce BDNF in a stroke moDel of monkeys. Neurosci Res 2009; 65: 71-78
38. Kraemer HC, Yesavage JA, Taylor JL, Kupfer D: How can we learn about Developmental processes from cross-sectional studies, or can we? Am J Psychiatry 2000; 157: 163-171
39. Thompson WK, Hallmayer J, OHara R: Alzheimers disease neuroimaging. I. Design consiDerations for characterizing psychiatric trajectories across the lifespan: application to effects of APOE-4 on cerebral cortical thickness in Alzheimers disease. Am J Psychiatry 2011; 168: 894-903